{
    "info": {
        "nct_id": "NCT04091022",
        "official_title": "A Randomized, Placebo-controlled, Double-blind, Phase II Chemoprevention Clinical Trial of Topical Diclofenac and DFMO in Subjects with a History of Skin Cancer",
        "inclusion_criteria": "Inclusion Criteria\n\n* Previous treatment for basal or squamous cell skin cancer stage 0-2 and current evidence of at least actinic keratosis on the upper extremities (upper arms, forearms and hands), neck, face or scalp.\n* >18 years of age\n* Ability to understand and willingness to sign a written informed consent document\n* ECOG performance status 0-1\n* Willing and able to participate for the full duration of the study\n* Willing to abstain from:\n\n  * The application of topical medications including prescription and over the counter preparations (e.g., Topical preparations containing corticosteroids or vitamin A derivatives) to intended treatment areas for the duration of the study. Use of moisturizers/emollients and sunscreens on these areas is allowed.\n  * Chronic (defined as > 3 times/week for more than 2 consecutive weeks/year) NSAID and COX-2 inhibitor use (other than cardioprotective doses of aspirin < 100 mg po QD) for the duration of the study\n* Normal organ and marrow function defined as laboratory values falling within the specified ranges for the following tests (performed within 365 days of registration)\n\nHematologic\n\n* WBC >3,000/ul\n* Hemoglobin > lower limit of normal\n* Platelet count > 100,000/ul\n\nHepatic\n\n* Total bilirubin < 1.5 X ULN\n* AST (SGOT) < 1.5 X ULN\n* ALT (SPGT) < 1.5 X ULN Renal\n* Serum creatinine < 1.5 X ULN BUN < 1.5 X ULN\n\n  • Females of childbearing potential must:\n* Have been using adequate contraception (abstinence, IUD, birth control pills or spermicidal gel with diaphragm or condom) since their last menses\n* Have a documented negative urine pregnancy test prior to the first dose of study medication. (Females are not considered to be of childbearing potential if they are at least 1 year post-menopausal or have had a tubal ligation, bilateral oophorectomy or hysterectomy)\n* The effects of DFMO and diclofenac on the developing fetus are unknown. Therefore, all females of childbearing potential and all men capable of fathering a child must agree to use adequate contraception (abstinence, IUD, birth control pills, or spermicidal gel with diaphragm or condom) for the duration of study participation.\n\nExclusion Criteria\n\nAny of the following will render a participant ineligible to participate in this study:\n\n* Aspirin >100 mg/day\n* Chronic (> 3 times/week for more than a two week period) use of NSAIDs or COX-2 inhibitors\n* Current use of topical steroids to intended treatment area (forearms)\n* Cryotherapy to intended treatment area (forearms) within the preceding 3 months\n* Use of oral or intravenous corticosteroids for more than 2 consecutive weeks\n\nAny of the following in the 4 weeks prior to randomization:\n\n* Major surgery for any indication\n* Cytotoxic chemotherapy for any indication (including methotrexate for arthritis)\n* Anti-cancer treatment of any type other than for a stage 0-2 non-melanoma skin cancer\n* Hormonal therapy for cancer prevention ((treatment with finasteride/dutasteride for BPH does not render a participant ineligible.)\n* Radiation therapy\n\nAny of the following in the 6 month prior to randomization to the intended treatment area (forearms):\n\n* Topical medications for the treatment of actinic keratosis or skin cancer (etretinate, 5-FU, imiquimod, ingenol)\n* Laser resurfacing, dermabrasion, chemical peel and/or electrodissection ± curettage\n\n  * Any family history of Ornithine diaminotransferase deficiency in a first degree relative\n  * Any personal history of:\n* Invasive cancer diagnosed or treated within the past 5 years. Participants who have been in remission for >5 years and have not required treatment in the past 5 years may be eligible if a study chair or principal investigator believes there is little to no risk of recurrence.\n* Solid organ or bone marrow transplant\n* Biopsy proven hepatic cirrhosis\n* Keloid formation\n* Photosensitivity disorder\n* Hypersensitivity or adverse reactions to nonsteroidal anti-inflammatory agents\n* Oral DFMO for > 1 month on a prior study\n* Any disease that predisposes to NMSC\n* An immunodeficiency disorder or the use of an immunosuppressive drug\n\n  • Concurrent use of the following medications or treatments:\n* Systemic therapy with psoralens, immunotherapy, or retinoids.\n* Cytotoxic chemotherapy for any reason (including methotrexate for arthritis)\n* Topical or systemic immunosuppressive therapy\n\n  * Females who are pregnant or lactating. Should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should notify her study physician immediately.\n  * Uncontrolled concurrent illness including ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled symptomatic cardiac arrhythmia, psychiatric illness/social situations that would limit compliance with study requirements or other underlying serious medical condition which, in the investigator's opinion might preclude study participation.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Biopsy proven hepatic cirrhosis",
            "criterions": [
                {
                    "exact_snippets": "Biopsy proven hepatic cirrhosis",
                    "criterion": "hepatic cirrhosis",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis_method",
                            "expected_value": "biopsy proven"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Solid organ or bone marrow transplant",
            "criterions": [
                {
                    "exact_snippets": "Solid organ ... transplant",
                    "criterion": "solid organ transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "bone marrow transplant",
                    "criterion": "bone marrow transplant",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Previous treatment for basal or squamous cell skin cancer stage 0-2 and current evidence of at least actinic keratosis on the upper extremities (upper arms, forearms and hands), neck, face or scalp.",
            "criterions": [
                {
                    "exact_snippets": "Previous treatment for basal or squamous cell skin cancer stage 0-2",
                    "criterion": "basal or squamous cell skin cancer",
                    "requirements": [
                        {
                            "requirement_type": "treatment history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": ""
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "current evidence of at least actinic keratosis on the upper extremities (upper arms, forearms and hands), neck, face or scalp",
                    "criterion": "actinic keratosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": [
                                "upper extremities (upper arms, forearms and hands)",
                                "neck",
                                "face",
                                "scalp"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Photosensitivity disorder",
            "criterions": [
                {
                    "exact_snippets": "Photosensitivity disorder",
                    "criterion": "photosensitivity disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any disease that predisposes to NMSC",
            "criterions": [
                {
                    "exact_snippets": "Any disease that predisposes to NMSC",
                    "criterion": "disease that predisposes to NMSC",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Radiation therapy",
            "criterions": [
                {
                    "exact_snippets": "Radiation therapy",
                    "criterion": "radiation therapy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* >18 years of age",
            "criterions": [
                {
                    "exact_snippets": ">18 years of age",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": ">",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Aspirin >100 mg/day",
            "criterions": [
                {
                    "exact_snippets": "Aspirin >100 mg/day",
                    "criterion": "aspirin dosage",
                    "requirements": [
                        {
                            "requirement_type": "dosage",
                            "expected_value": {
                                "operator": ">",
                                "value": 100,
                                "unit": "mg/day"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* WBC >3,000/ul",
            "criterions": [
                {
                    "exact_snippets": "WBC >3,000/ul",
                    "criterion": "white blood cell count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 3000,
                                "unit": "/ul"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ALT (SPGT) < 1.5 X ULN Renal",
            "criterions": [
                {
                    "exact_snippets": "ALT (SPGT) < 1.5 X ULN",
                    "criterion": "ALT (SPGT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hormonal therapy for cancer prevention ((treatment with finasteride/dutasteride for BPH does not render a participant ineligible.)",
            "criterions": [
                {
                    "exact_snippets": "Hormonal therapy for cancer prevention",
                    "criterion": "hormonal therapy for cancer prevention",
                    "requirements": [
                        {
                            "requirement_type": "history of use",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "treatment with finasteride/dutasteride for BPH does not render a participant ineligible",
                    "criterion": "treatment with finasteride/dutasteride for BPH",
                    "requirements": [
                        {
                            "requirement_type": "history of use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic (> 3 times/week for more than a two week period) use of NSAIDs or COX-2 inhibitors",
            "criterions": [
                {
                    "exact_snippets": "Chronic (> 3 times/week for more than a two week period) use of NSAIDs or COX-2 inhibitors",
                    "criterion": "use of NSAIDs",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "times/week"
                            }
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Chronic (> 3 times/week for more than a two week period) use of ... COX-2 inhibitors",
                    "criterion": "use of COX-2 inhibitors",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "times/week"
                            }
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Anti-cancer treatment of any type other than for a stage 0-2 non-melanoma skin cancer",
            "criterions": [
                {
                    "exact_snippets": "Anti-cancer treatment of any type other than for a stage 0-2 non-melanoma skin cancer",
                    "criterion": "anti-cancer treatment",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": "treatment for stage 0-2 non-melanoma skin cancer allowed"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing to abstain from:",
            "criterions": [
                {
                    "exact_snippets": "Willing to abstain from:",
                    "criterion": "willingness to abstain",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "• Females of childbearing potential must:",
            "criterions": [
                {
                    "exact_snippets": "Females of childbearing potential",
                    "criterion": "sex and reproductive potential",
                    "requirements": [
                        {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        },
                        {
                            "requirement_type": "reproductive potential",
                            "expected_value": "of childbearing potential"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing and able to participate for the full duration of the study",
            "criterions": [
                {
                    "exact_snippets": "Willing ... to participate for the full duration of the study",
                    "criterion": "willingness to participate",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "able to participate for the full duration of the study",
                    "criterion": "ability to participate for the full duration of the study",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The effects of DFMO and diclofenac on the developing fetus are unknown. Therefore, all females of childbearing potential and all men capable of fathering a child must agree to use adequate contraception (abstinence, IUD, birth control pills, or spermicidal gel with diaphragm or condom) for the duration of study participation.",
            "criterions": [
                {
                    "exact_snippets": "all females of childbearing potential ... must agree to use adequate contraception (abstinence, IUD, birth control pills, or spermicidal gel with diaphragm or condom) for the duration of study participation",
                    "criterion": "contraception use (females of childbearing potential)",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "for the duration of study participation"
                        }
                    ]
                },
                {
                    "exact_snippets": "all men capable of fathering a child must agree to use adequate contraception (abstinence, IUD, birth control pills, or spermicidal gel with diaphragm or condom) for the duration of study participation",
                    "criterion": "contraception use (men capable of fathering a child)",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "for the duration of study participation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hemoglobin > lower limit of normal",
            "criterions": [
                {
                    "exact_snippets": "Hemoglobin > lower limit of normal",
                    "criterion": "hemoglobin",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": {
                                "operator": ">",
                                "value": 0,
                                "unit": "lower limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Topical or systemic immunosuppressive therapy",
            "criterions": [
                {
                    "exact_snippets": "Topical or systemic immunosuppressive therapy",
                    "criterion": "immunosuppressive therapy",
                    "requirements": [
                        {
                            "requirement_type": "route of administration",
                            "expected_value": [
                                "topical",
                                "systemic"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "Any of the following in the 4 weeks prior to randomization:",
            "criterions": [
                {
                    "exact_snippets": "Any of the following in the 4 weeks prior to randomization",
                    "criterion": "occurrence of specified events or conditions",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 4,
                                "unit": "weeks prior to randomization"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cryotherapy to intended treatment area (forearms) within the preceding 3 months",
            "criterions": [
                {
                    "exact_snippets": "Cryotherapy to intended treatment area (forearms) within the preceding 3 months",
                    "criterion": "cryotherapy to forearms",
                    "requirements": [
                        {
                            "requirement_type": "time since procedure",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "• Concurrent use of the following medications or treatments:",
            "criterions": [
                {
                    "exact_snippets": "Concurrent use of the following medications or treatments",
                    "criterion": "concurrent use of specified medications or treatments",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Females who are pregnant or lactating. Should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should notify her study physician immediately.",
            "criterions": [
                {
                    "exact_snippets": "Females who are pregnant",
                    "criterion": "pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "pregnant",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "lactating",
                    "criterion": "lactation status",
                    "requirements": [
                        {
                            "requirement_type": "lactating",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Invasive cancer diagnosed or treated within the past 5 years. Participants who have been in remission for >5 years and have not required treatment in the past 5 years may be eligible if a study chair or principal investigator believes there is little to no risk of recurrence.",
            "criterions": [
                {
                    "exact_snippets": "Invasive cancer diagnosed or treated within the past 5 years",
                    "criterion": "invasive cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis or treatment timing",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "years ago"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Participants who have been in remission for >5 years and have not required treatment in the past 5 years",
                    "criterion": "remission duration and treatment requirement",
                    "requirements": [
                        {
                            "requirement_type": "remission duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "years"
                            }
                        },
                        {
                            "requirement_type": "treatment requirement",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "if a study chair or principal investigator believes there is little to no risk of recurrence",
                    "criterion": "risk of recurrence (as judged by investigator)",
                    "requirements": [
                        {
                            "requirement_type": "risk of recurrence",
                            "expected_value": "little to no risk (as judged by study chair or principal investigator)"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability to understand and willingness to sign a written informed consent document",
            "criterions": [
                {
                    "exact_snippets": "Ability to understand",
                    "criterion": "cognitive ability",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to provide informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Oral DFMO for > 1 month on a prior study",
            "criterions": [
                {
                    "exact_snippets": "Oral DFMO for > 1 month on a prior study",
                    "criterion": "oral DFMO treatment duration",
                    "requirements": [
                        {
                            "requirement_type": "duration_on_prior_study",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Hematologic",
            "criterions": [
                {
                    "exact_snippets": "Hematologic",
                    "criterion": "hematologic status",
                    "requirements": [
                        {
                            "requirement_type": "N/A",
                            "expected_value": "meets protocol-specified hematologic criteria"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cytotoxic chemotherapy for any reason (including methotrexate for arthritis)",
            "criterions": [
                {
                    "exact_snippets": "Cytotoxic chemotherapy for any reason (including methotrexate for arthritis)",
                    "criterion": "cytotoxic chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "exposure/use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Keloid formation",
            "criterions": [
                {
                    "exact_snippets": "Keloid formation",
                    "criterion": "keloid formation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* An immunodeficiency disorder or the use of an immunosuppressive drug",
            "criterions": [
                {
                    "exact_snippets": "An immunodeficiency disorder",
                    "criterion": "immunodeficiency disorder",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "the use of an immunosuppressive drug",
                    "criterion": "immunosuppressive drug use",
                    "requirements": [
                        {
                            "requirement_type": "use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Use of oral or intravenous corticosteroids for more than 2 consecutive weeks",
            "criterions": [
                {
                    "exact_snippets": "Use of oral or intravenous corticosteroids for more than 2 consecutive weeks",
                    "criterion": "corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "route of administration",
                            "expected_value": [
                                "oral",
                                "intravenous"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "consecutiveness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Laser resurfacing, dermabrasion, chemical peel and/or electrodissection ± curettage",
            "criterions": [
                {
                    "exact_snippets": "Laser resurfacing",
                    "criterion": "laser resurfacing",
                    "requirements": [
                        {
                            "requirement_type": "history or planned procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "dermabrasion",
                    "criterion": "dermabrasion",
                    "requirements": [
                        {
                            "requirement_type": "history or planned procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "chemical peel",
                    "criterion": "chemical peel",
                    "requirements": [
                        {
                            "requirement_type": "history or planned procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "electrodissection ± curettage",
                    "criterion": "electrodissection with or without curettage",
                    "requirements": [
                        {
                            "requirement_type": "history or planned procedure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Uncontrolled concurrent illness including ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled symptomatic cardiac arrhythmia, psychiatric illness/social situations that would limit compliance with study requirements or other underlying serious medical condition which, in the investigator's opinion might preclude study participation.",
            "criterions": [
                {
                    "exact_snippets": "Uncontrolled concurrent illness including ongoing or active infection",
                    "criterion": "concurrent illness",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    ]
                },
                {
                    "exact_snippets": "ongoing or active infection",
                    "criterion": "infection",
                    "requirements": [
                        {
                            "requirement_type": "activity status",
                            "expected_value": [
                                "ongoing",
                                "active"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "symptomatic congestive heart failure",
                    "criterion": "congestive heart failure",
                    "requirements": [
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        }
                    ]
                },
                {
                    "exact_snippets": "unstable angina pectoris",
                    "criterion": "angina pectoris",
                    "requirements": [
                        {
                            "requirement_type": "stability",
                            "expected_value": "unstable"
                        }
                    ]
                },
                {
                    "exact_snippets": "uncontrolled symptomatic cardiac arrhythmia",
                    "criterion": "cardiac arrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        },
                        {
                            "requirement_type": "symptom status",
                            "expected_value": "symptomatic"
                        }
                    ]
                },
                {
                    "exact_snippets": "psychiatric illness/social situations that would limit compliance with study requirements",
                    "criterion": "psychiatric illness or social situation",
                    "requirements": [
                        {
                            "requirement_type": "impact on compliance",
                            "expected_value": "would limit compliance with study requirements"
                        }
                    ]
                },
                {
                    "exact_snippets": "other underlying serious medical condition which, in the investigator's opinion might preclude study participation",
                    "criterion": "serious medical condition",
                    "requirements": [
                        {
                            "requirement_type": "investigator opinion on participation",
                            "expected_value": "might preclude study participation"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status 0-1",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status 0-1",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 1,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "Any of the following in the 6 month prior to randomization to the intended treatment area (forearms):",
            "criterions": [
                {
                    "exact_snippets": "Any of the following in the 6 month prior to randomization to the intended treatment area (forearms):",
                    "criterion": "presence of specified conditions or interventions in the intended treatment area (forearms)",
                    "requirements": [
                        {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        },
                        {
                            "requirement_type": "location",
                            "expected_value": "intended treatment area (forearms)"
                        },
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Topical medications for the treatment of actinic keratosis or skin cancer (etretinate, 5-FU, imiquimod, ingenol)",
            "criterions": [
                {
                    "exact_snippets": "Topical medications for the treatment of actinic keratosis or skin cancer (etretinate, 5-FU, imiquimod, ingenol)",
                    "criterion": "topical medications for actinic keratosis or skin cancer",
                    "requirements": [
                        {
                            "requirement_type": "use/presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "medication_names",
                            "expected_value": [
                                "etretinate",
                                "5-FU",
                                "imiquimod",
                                "ingenol"
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Systemic therapy with psoralens, immunotherapy, or retinoids.",
            "criterions": [
                {
                    "exact_snippets": "Systemic therapy with psoralens",
                    "criterion": "systemic therapy with psoralens",
                    "requirements": [
                        {
                            "requirement_type": "exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Systemic therapy with ... immunotherapy",
                    "criterion": "systemic therapy with immunotherapy",
                    "requirements": [
                        {
                            "requirement_type": "exposure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Systemic therapy with ... retinoids",
                    "criterion": "systemic therapy with retinoids",
                    "requirements": [
                        {
                            "requirement_type": "exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Normal organ and marrow function defined as laboratory values falling within the specified ranges for the following tests (performed within 365 days of registration)",
            "criterions": [
                {
                    "exact_snippets": "Normal organ and marrow function defined as laboratory values falling within the specified ranges",
                    "criterion": "organ and marrow function",
                    "requirements": [
                        {
                            "requirement_type": "laboratory values within specified ranges",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "performed within 365 days of registration",
                    "criterion": "laboratory tests timing",
                    "requirements": [
                        {
                            "requirement_type": "time since test",
                            "expected_value": {
                                "operator": "<=",
                                "value": 365,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Chronic (defined as > 3 times/week for more than 2 consecutive weeks/year) NSAID and COX-2 inhibitor use (other than cardioprotective doses of aspirin < 100 mg po QD) for the duration of the study",
            "criterions": [
                {
                    "exact_snippets": "Chronic (defined as > 3 times/week for more than 2 consecutive weeks/year) NSAID and COX-2 inhibitor use (other than cardioprotective doses of aspirin < 100 mg po QD) for the duration of the study",
                    "criterion": "NSAID and COX-2 inhibitor use",
                    "requirements": [
                        {
                            "requirement_type": "frequency",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 3,
                                        "unit": "times/week"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 2,
                                        "unit": "consecutive weeks/year"
                                    }
                                ]
                            }
                        },
                        {
                            "requirement_type": "exclusion",
                            "expected_value": "except cardioprotective doses of aspirin < 100 mg po QD"
                        },
                        {
                            "requirement_type": "duration_of_study",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Platelet count > 100,000/ul",
            "criterions": [
                {
                    "exact_snippets": "Platelet count > 100,000/ul",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 100000,
                                "unit": "/ul"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* The application of topical medications including prescription and over the counter preparations (e.g., Topical preparations containing corticosteroids or vitamin A derivatives) to intended treatment areas for the duration of the study. Use of moisturizers/emollients and sunscreens on these areas is allowed.",
            "criterions": [
                {
                    "exact_snippets": "The application of topical medications including prescription and over the counter preparations (e.g., Topical preparations containing corticosteroids or vitamin A derivatives) to intended treatment areas for the duration of the study.",
                    "criterion": "application of topical medications to intended treatment areas",
                    "requirements": [
                        {
                            "requirement_type": "prohibition",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Use of moisturizers/emollients and sunscreens on these areas is allowed.",
                    "criterion": "use of moisturizers/emollients and sunscreens on intended treatment areas",
                    "requirements": [
                        {
                            "requirement_type": "allowance",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Hypersensitivity or adverse reactions to nonsteroidal anti-inflammatory agents",
            "criterions": [
                {
                    "exact_snippets": "Hypersensitivity or adverse reactions to nonsteroidal anti-inflammatory agents",
                    "criterion": "hypersensitivity to nonsteroidal anti-inflammatory agents",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Hypersensitivity or adverse reactions to nonsteroidal anti-inflammatory agents",
                    "criterion": "adverse reactions to nonsteroidal anti-inflammatory agents",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* AST (SGOT) < 1.5 X ULN",
            "criterions": [
                {
                    "exact_snippets": "AST (SGOT) < 1.5 X ULN",
                    "criterion": "AST (SGOT) level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any family history of Ornithine diaminotransferase deficiency in a first degree relative",
            "criterions": [
                {
                    "exact_snippets": "Any family history of Ornithine diaminotransferase deficiency in a first degree relative",
                    "criterion": "family history of Ornithine diaminotransferase deficiency in a first degree relative",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Cytotoxic chemotherapy for any indication (including methotrexate for arthritis)",
            "criterions": [
                {
                    "exact_snippets": "Cytotoxic chemotherapy for any indication (including methotrexate for arthritis)",
                    "criterion": "cytotoxic chemotherapy",
                    "requirements": [
                        {
                            "requirement_type": "exposure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have been using adequate contraception (abstinence, IUD, birth control pills or spermicidal gel with diaphragm or condom) since their last menses",
            "criterions": [
                {
                    "exact_snippets": "Have been using adequate contraception (abstinence, IUD, birth control pills or spermicidal gel with diaphragm or condom) since their last menses",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "method",
                            "expected_value": [
                                "abstinence",
                                "IUD",
                                "birth control pills",
                                "spermicidal gel with diaphragm",
                                "spermicidal gel with condom"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "since their last menses"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Hepatic",
            "criterions": [
                {
                    "exact_snippets": "Hepatic",
                    "criterion": "hepatic function",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Total bilirubin < 1.5 X ULN",
            "criterions": [
                {
                    "exact_snippets": "Total bilirubin < 1.5 X ULN",
                    "criterion": "total bilirubin",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Major surgery for any indication",
            "criterions": [
                {
                    "exact_snippets": "Major surgery for any indication",
                    "criterion": "major surgery",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any personal history of:",
            "criterions": [
                {
                    "exact_snippets": "Any personal history of:",
                    "criterion": "personal history",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Current use of topical steroids to intended treatment area (forearms)",
            "criterions": [
                {
                    "exact_snippets": "Current use of topical steroids to intended treatment area (forearms)",
                    "criterion": "topical steroid use to intended treatment area (forearms)",
                    "requirements": [
                        {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum creatinine < 1.5 X ULN BUN < 1.5 X ULN",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine < 1.5 X ULN",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "X ULN"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "BUN < 1.5 X ULN",
                    "criterion": "BUN",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1.5,
                                "unit": "X ULN"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Have a documented negative urine pregnancy test prior to the first dose of study medication. (Females are not considered to be of childbearing potential if they are at least 1 year post-menopausal or have had a tubal ligation, bilateral oophorectomy or hysterectomy)",
            "criterions": [
                {
                    "exact_snippets": "documented negative urine pregnancy test prior to the first dose of study medication",
                    "criterion": "urine pregnancy test",
                    "requirements": [
                        {
                            "requirement_type": "result",
                            "expected_value": "negative"
                        },
                        {
                            "requirement_type": "documentation",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to the first dose of study medication"
                        }
                    ]
                },
                {
                    "exact_snippets": "Females are not considered to be of childbearing potential if they are at least 1 year post-menopausal",
                    "criterion": "menopausal status",
                    "requirements": [
                        {
                            "requirement_type": "post-menopausal duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "year"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "Females are not considered to be of childbearing potential if they ... have had a tubal ligation",
                    "criterion": "tubal ligation",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Females are not considered to be of childbearing potential if they ... have had a ... bilateral oophorectomy",
                    "criterion": "bilateral oophorectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Females are not considered to be of childbearing potential if they ... have had a ... hysterectomy",
                    "criterion": "hysterectomy",
                    "requirements": [
                        {
                            "requirement_type": "history of procedure",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Inclusion Criteria",
            "criterions": []
        },
        {
            "line": "Exclusion Criteria",
            "criterions": []
        },
        {
            "line": "Any of the following will render a participant ineligible to participate in this study:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}